Jump to content
IndiaDivine.org
Sign in to follow this  
Guest guest

Zyflamend and prostate cancer

Rate this topic

Recommended Posts

Guest guest

Hi All, & Ihor,

 

Ihor wrote:

> http://tinyurl.com/9voro says: An herbal extract developed by New

> Chapter suppresses the growth of prostate cancer cells and induces

> prostate cancer cells to self-destruct, according to new research.

 

> The data, published in the October edition of Nutrition and Cancer

> (vol 52, issue 2, pp202-12), showed that Zyflamend reduces prostate

> cancer cell proliferation in vitro by as much as 78%.

 

> The supplement contains extracts of rosemary, turmeric, ginger, holy

> basil, green tea, huzhang (Polygonum cuspidati, ie Giant Knotweed

> Rhizome), Chinese goldthread, barberry, oregano, and Huangqin-Baikal

> skullcap. " These results were particularly surprising and show great

> promise in the fight against prostate cancer, " said researcher Dr Debra

> Bemis of Columbia University's Department of Urology.

 

Many thanks, Ihor. The new findings are interesting because Zyflamend

was promoted originally for joint problems & inflammation. There was

no mention of its use in prostate cancer originally. See:

 

NMK08001 Zyflamend 60g/Joint+Inflam

DETAILS: Zyflamend blends 10 herbs containing at least 78 known

active constituents shown to inhibit the COX-2 enzyme associated with

inflammation.

 

Zyflamend promotes normal cell growth, healthy joint function, normal

muscle and soft tissue function, supports cardiovascular function and

normal cognition, and provides a rich source of antioxidants to protect

against the undesirable effects of aging.

 

INGREDIENTS: SIZE: 2 X 30g gels/SERVINGS/CONTAINER

 

AMOUNT PER SERVING:

Rosemary Fm 100mg supercritical extract and 50mg extract(23% total

phenolic antioxidants TPA 345mg) 150 mg

 

Turmeric Rz 10mg supercritical extract (45% tumerones 4.5mg) and

100mg PSE extract (7% curcumin 7mg) 110 mg

 

Ginger Rz 54mg supecritical extract (30% pungent compounds 16.2mg,

8% zingiberene 4.3mg) and 46mg PSE extract (3% pungent

compounds 1.4mg) 100 mg

 

Holy Basil Fm extract (2% ursolic acid 2mg) 100 mg

 

Green Tea Fm extract (45% polyphenols 45mg) 100 mg

 

Huzhang-Polgonum cuspidatum Rx+Rz extract (8% resveratrol 6.4mg)

80 mg

 

Huanglian-Chinese Goldthread Rx extract (6% berberine 2.4mg) 40 mg

 

Barberry Rx extract (6% berberine 2.4mg) 40 mg

 

Oregano Fm supercritical extract (0.8 TPA 0.32mg) 40 mg

 

Huangqin-Baikal Scullcap Rx Scutellaria balcalensis hydroethanolic

extract(17-26% balcalein complex including baicalein and balcalin 3.4-

5.2mg and 0.4-0.9% wogonin 0.8-0.18mg) 20 mg

 

Olive oil (extra virgin), maltodextrin, silica, yellow beeswax, gelatin

capsule, vegetable glycerin, purified water, and carob.

 

RECOMMENDED USAGE: Take 1 softgel, bid, with meals or as

directed by your health care provider.

 

NOTE: Women who are nursing, pregnant or contemplating pregnancy,

should consult with their health care provider before taking this product.

 

Best regards,

 

HOME + WORK: 1 Esker Lawns, Lucan, Dublin, Ireland

Tel: (H): +353-(0) or (M): +353-(0)

<

 

 

 

" Man who says it can't be done should not interrupt man doing it " -

Chinese Proverb

 

 

 

Share this post


Link to post
Share on other sites
Guest guest

Hi All, & Ihor,

 

Re: Zyflamend and Prostate Cancer, note that the encouraging in-vitro

(LAB) results have NOT been assessed in clinical human cases yet.

 

http://www.thehealthierlife.co.uk/article/3471/prostate-cancer.html says

that the Columbia team has started to test Zyflamend in a human trial

that's already underway. The study [funded by the manufacturers, New

Chapter Inc., Battleboro, VT) is designed to examine the effects of

Zyflamend on patients who are diagnosed with prostatic intraepithelial

neoplasia (PIN). PIN is a condition in which the cells on the prostate

gland's surface divide more rapidly than the rest of the prostate cells.

Research shows that men diagnosed with PIN have a sharply increased

risk of developing prostate cancer. Researchers are examining the use

of Zyflamend on nearly 50 men, aged 40-75, who have been diagnosed

with PIN. The trial period will run for 18 months, so the results will not

be available until next year at the earliest.

 

See http://www.hnherbs.com/inflammationdirectscan.pdf for a useful

article: " Inflammation Control Options from Nature " By Yousry Naguib,

Ph.D. That article summarises some of the actions of the ingredients in

Zyflamend.

 

Note that Dr. Naguib has an interest in Soft Gel Technologies Inc (Los

Angeles), and that Zyflamend (New Chapter Inc., Battleboro, VT) uses

softgel in its delivery system.

 

Best regards,

 

HOME + WORK: 1 Esker Lawns, Lucan, Dublin, Ireland

Tel: (H): +353-(0) or (M): +353-(0)

<

 

 

 

 

 

Share this post


Link to post
Share on other sites
Guest guest

Hi All, & Ihor,

 

Re: Zyflamend and Prostate Cancer, note that the encouraging in-vitro

(LAB) results have NOT been assessed in clinical human cases yet.

 

http://www.thehealthierlife.co.uk/article/3471/prostate-cancer.html says

that the Columbia team has started to test Zyflamend in a human trial

that's already underway. The study [funded by the manufacturers, New

Chapter Inc., Battleboro, VT) is designed to examine the effects of

Zyflamend on patients who are diagnosed with prostatic intraepithelial

neoplasia (PIN). PIN is a condition in which the cells on the prostate

gland's surface divide more rapidly than the rest of the prostate cells.

Research shows that men diagnosed with PIN have a sharply increased

risk of developing prostate cancer. Researchers are examining the use

of Zyflamend on nearly 50 men, aged 40-75, who have been diagnosed

with PIN. The trial period will run for 18 months, so the results will not

be available until next year at the earliest.

 

See http://www.hnherbs.com/inflammationdirectscan.pdf for a useful

article: " Inflammation Control Options from Nature " By Yousry Naguib,

Ph.D. That article summarises some of the actions of the ingredients in

Zyflamend.

 

Note that Dr. Naguib has an interest in Soft Gel Technologies Inc (Los

Angeles), and that Zyflamend (New Chapter Inc., Battleboro, VT) uses

softgel in its delivery system.

 

Best regards,

 

HOME + WORK: 1 Esker Lawns, Lucan, Dublin, Ireland

Tel: (H): +353-(0) or (M): +353-(0)

<

 

 

 

 

 

Share this post


Link to post
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
Sign in to follow this  

×
×
  • Create New...